Survival in severe alpha-1-antitrypsin deficiency (PiZZ)

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Tanash, Hanan A ^a   Nilsson, Peter M ^a   Nilsson, Jan Åke ^a   Piitulainen, Eeva ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL INFECTION; ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ASTHMA; BRONCHIECTASIS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC BRONCHITIS; EMPHYSEMA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTROINTESTINAL HEMORRHAGE; HUMAN; KIDNEY FAILURE; LIVER CARCINOMA; LIVER DISEASE; LIVER FAILURE; LUNG EMBOLISM; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PNEUMOTHORAX; RECURRENT INFECTION; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; SMOKING; SUICIDE; SURVIVAL; SWEDEN; ADOLESCENT; DISEASE COURSE; HOSPITALIZATION; KAPLAN MEIER METHOD; LUNG; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK; RISK ASSESSMENT; RISK FACTOR; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN DEFICIENCY; CAUSE OF DEATH; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 77954639932     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-44     Document Type: Article

References (17)

1. American Thoracic Society/European Respiratory Society statement standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003, 168:818-900. 10.1164/rccm.168.7.818, 14522813, American Thoracic Society/European Respiratory Society statement.
2. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta med Scand 1978, 204:345-51.
3. Eriksson S. Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl 1965, 432:1-85.
4. Hutchison DC. Natural history of alpha-1-protease inhibitor deficiency. Am J Med 1988, 84:3-12.
5. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976, 294:1316-21.
6. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 1986, 314:736-9.
7. Tanash HA, Nilsson PM, Nilsson JA, Piitulainen E. Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ). Thorax 2008, 63:1091-5. 10.1136/thx.2008.095497, 18682522.
8. Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). Thorax 1997, 52:244-8. 10.1136/thx.52.3.244, 1758519, 9093340.
9. Quanjer P. Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir 1983, 19(Suppl 5):1-95.
10. Quanjer P. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:1-100.
11. Spjotvoll E, Stoline MR. An extension of the T-method of multiple comparison to include the cases with unequal sample sizes. J Am Stat Assoc 1973, 68:976-8.
12. Statistics Sweden (Bureau of Statistics in Stockholm): 1991-2007. , http://www.ssd.scb.se
13. Silverman EK, Pierce JA, Province MA, Rao DC, Campbell EJ. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. Ann Intern Med 1989, 111:982-91.
14. Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988, 138:327-36.
15. Seersholm N, Kok-Jensen A, Dirksen A. Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases. Thorax 1994, 49:695-8. 10.1136/thx.49.7.695, 475060, 8066566.
16. Seersholm N, Kok-Jensen A. Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency. Am J Respir Crit Care Med 1995, 151:369-73.
17. Stoller JK, Tomashefski J, Crystal RG, Arroliga A, Strange C, Killian DN, Schluchter MD, Wiedemann HP. Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry. Chest 2005, 127:1196-204. 10.1378/chest.127.4.1196, 15821195.